EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre

Jonathan Croos iD, Adam Kia Shooshtarian iD, Ben Stotesbury, Geraldine Gallen, Khalida Ismail iD, Miranda Rosenthal, Yee Cheah, Marilia Calcia, Kaylee Lovie, Anusha Ahuja, Aakanksha Shrestha, Rachael J L Tan iD und 1 weitere

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Jonathan Croos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Faculty of Life Sciences and Medicine, King's College London, London, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Anxiety Disorders, Insulin Infusion Systems, Insulin. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Institute of Health and Care Research NIHR (Clinical Lecturership), NIHR Mental Health Biomedical Research Centre at South London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Retrospective study evaluating real‐world outcomes of hybrid closed‐loop (HCL) in adults with type 1 diabetes and comorbid depression and/or anxiety disorders. Materials and methods Adults with type 1 diabetes and comorbid depression/anxiety disorders attending King's College Hospital diabetes centre between October 2023 and January 2025 were included. Demographic, medical and psychiatric information, acute diabetes complication rates, two‐item diabetes distress scale (DDS2) scores and sensor glucometrics (time in range; TIR) were extracted from electronic health records and diabetes technology platforms.

Results

Of 1827 adults with type 1 diabetes, 226 had comorbid depressive and/or anxiety disorders [163 female/63 male; age 38 (IQR: 29.0–51.3) years, 23 (15–33.3) years diabetes duration]; 196 had depression and 119 had anxiety disorders. HCL‐users ( n = 108; 89 female/19 male) had lower glycated haemoglobin A 1c (HbA 1c ) and higher TIR [HbA 1c 60.0 mmol/mol (7.6%) (53.0–66.0/7.0–8.2) vs. 73.0 mmol/mol (8.8%) (58.5–85.5/7.5–10.0), p < 0.001; TIR 63.5 (55.8–75.0) vs. 42.0 (23.0–55.3), p < 0.001] than non‐HCL users ( n = 118, 44 female/74 male) at last follow‐up compared to baseline. Glycaemia improved post HCL‐initiation compared to pre‐HCL [HbA 1c 60.0 mmol/mol (7.6%) (53.0–66.0/7.0–8.2) vs. 67.5 mmol/mol (8.3%) (58.8–77.8/7.5–9.3), p < 0.001; TIR 63.5 (55.8–75.0) vs. 39.0 (28.0–55.8), p < 0.001]. Severe hypoglycaemia rates did not vary ( p = 0.380), but fewer HCL users experienced ketoacidosis ( p < 0.001). DDS2 scores were lower post‐HCL ( p = 0.004) but not when comparing HCL and non‐HCL users ( p = 0.230).

Conclusions

HCL users demonstrated improved HbA 1c and TIR, compared with non‐HCL users. These real‐world data support safe use of HCL in people with type 1 diabetes and depression/anxiety in a multidisciplinary setting. Qualitative studies and prospective trials are required to further evaluate the impact of HCL on biomedical and mental health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Anxiety DisordersInsulin Infusion SystemsInsulinHypoglycemic AgentsDepressionHumansMaleFemaleRetrospective StudiesAdultMiddle AgedComorbidityBlood GlucoseTertiary Care CentersGlycated HemoglobinYoung AdultTreatment OutcomeAdolescentHypoglycemiaBlood Glucose Self-MonitoringContinuous Glucose MonitoringGlycemic Control

Stichwörter der Autor:innen

glycaemic controlinsulin pump therapyreal‐world evidencetype 1 diabetes

Substanzen

InsulinBlood GlucoseGlycated HemoglobinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Diabetes, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Department of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
  • Psychiatry Research Group, Department of Psychological Medicine, Diabetes, and Psychology, King's College London, London, UK.
  • Clinical Diabetes Research Group, School of Cardiovascular and Metabolic Medicine and Sciences, London, UK.

ORCID-Profile: Jonathan Croos, Adam Kia Shooshtarian, Khalida Ismail, Rachael J L Tan, Marietta Stadler

Förderung

  • National Institute of Health and Care Research NIHR (Clinical Lecturership)
  • NIHR Mental Health Biomedical Research Centre at South London

Zitieren

APA

Croos, J., Shooshtarian, A. K., Stotesbury, B., Gallen, G., Ismail, K., Rosenthal, M., Cheah, Y., Calcia, M., Lovie, K., Ahuja, A., Shrestha, A., Tan, R. J. L., & Stadler, M. (2026). Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70432

Vancouver

Croos J, Shooshtarian AK, Stotesbury B, Gallen G, Ismail K, Rosenthal M, et al. Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70432

BibTeX
@article{Croos2026,
  author = {Croos, Jonathan and Shooshtarian, Adam Kia and Stotesbury, Ben and Gallen, Geraldine and Ismail, Khalida and Rosenthal, Miranda and Cheah, Yee and Calcia, Marilia and Lovie, Kaylee and Ahuja, Anusha and Shrestha, Aakanksha and Tan, Rachael J L and Stadler, Marietta},
  title = {Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70432}
}
Kostenlos starten →